drugset / Trial / NCT01906788
The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Phase 4
Unknown
250 enrolled
Kilimanjaro Clinical Research Institute
Ifakara Health Institute · collabLondon School of Hygiene and Tropical Medicine · collab
RandomizedSingle-groupOpen-label
Summary
The investigators' Hypothesis is that "The correct timing of gametocytocidal drug in combination with an effective Artemisinin Combination Therapy can limit the infectiousness of malaria-infected individuals to less than one week after initiation of treatment"
Timeline
- Start
- 2013-05
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Primaquine | Small molecule | 0.75 mg/kg | — |
| Comparator | Artemether-lumefantrine | Unknown | — | Oral |